Researchers at Oxford and Nottingham Universities have found a method of significantly slowing the growth of triple negative breast cancer – the most aggressive form. The scientists tested a new drug, JQ1, which can attack cancerous tumors in deeper regions than conventional therapies.
According to an article by Henry Bodkin in The Telegraph, the drug was able to slow the growth of cancerous tumors by about a third each day. Researchers predict that combining the drug with chemotherapy and radiotherapy could bring “added benefits” to patients with a triple negative variation of breast cancer.
To read the full article, visit: http://www.telegraph.co.uk/science/2016/06/13/drug-found-that-significantly-reduces-growth-of-most-aggressive/